This biotech setup is making a BIG move 🧪

Check out what’s going on...

March 05, 2026

Hey Folks, Jeff Bishop here,

The market has been choppy thanks to the Iran war, but things took a turn for the green yesterday. The S&P 500 climbed about 0.8%, and the Nasdaq closed up 1.3%.

I’m pleased to say yesterday’s “tactical trade” idea surged well above the indexes and into double-digit territory:

I hope you’ve been paying attention!

This morning, I’m focused on a biotech that ripped nearly 14% intraday when I alerted it last month, and right now it’s up more than 30% since that alert.

But the chart is only part of the story…

Under the hood, this company has been stacking up one catalyst after another.

For starters, its lead drug candidate targeting major depressive disorder has received an FDA Breakthrough Therapy Designation, and in a controlled study, 100% of participants responded to treatment after 12 months, and 71% were in full remission after just two doses.

Meanwhile, the company has another program targeting anxiety disorders that has already completed enrollment in a Phase 2 trial.

Topline data from that study is expected in Q1 2026, so potentially any day now.

Since I last wrote about this one, the company brought on a former Pfizer Chief Medical Officer to the company’s board and as chair of its scientific advisory committee.

On top of all that, the company was sitting on a staggering $195 million in cash as of December 31, giving it a strong runway heading into multiple clinical catalysts.

The stock has attracted analyst attention from big names like Jefferies, Guggenheim, and Bloom Burton, all of whom have price targets that are multiples of the current stock price.

The stock jumped 8% yesterday, and I’m watching it closely today to see if that momentum stays strong.

Take a few minutes to look through the details and get this one on your radar.

With topline data due out any day now, this one could be fueling up for takeoff.

To Your Success,

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/.  

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any  SV Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. SV strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. SV Services may contain information regarding the historical trading performance of SV owners or employees, and/or testimonials of non-employees (including affiliates) depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, trading results of third parties may NOT have been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT guaranteed as TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

SHERWOOD VENTURES IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither SV nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

WE MAY HOLD SECURITIES DISCUSSED. SV, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

*AFFILIATE LINKS:If you purchase anything through a link in this email other than SV services, we earn a commission from the company providing that product. We have affiliate relationships with these companies and receive compensation when you make purchases through our links. We recommend that you do your own independent research before purchasing anything.  We are not responsible for any content hosted on affiliate sites and it is the affiliate's responsibility to ensure compliance with applicable laws.